![](/img/cover-not-exists.png)
Afatinib plus cetuximab delays resistance compared to single agent erlotinib or afatinib in mouse models of TKI-naive EGFR L858R-induced lung adenocarcinoma
Pirazzoli, V., Ayeni, D., Meador, C. B., Sanganahalli, B., Hyder, F., de Stanchina, E., Goldberg, S. B., Pao, W., Politi, K.Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-0620
Date:
September, 2015
File:
PDF, 1.12 MB
english, 2015